These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 875875)

  • 1. [Treatment of glomerulonephritis with heparin (author's transl)].
    Quellhorst E; Reichel W; Fernandez-Redo E; Scheler F
    Med Klin; 1977 Jun; 72(22):981-7. PubMed ID: 875875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with anticoagulants in glomerulonephritis (author's transl)].
    Girndt J
    Med Klin; 1979 Nov; 74(47):1767-71. PubMed ID: 522818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
    Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of heparin in the treatment of idiopathic rapidly progressive glomerulonephritis.
    Suc JM; Durand D; Conte J; Mignon-Conte M; Orfila C; That HT; Duchet JP
    Clin Nephrol; 1976 Jan; 5(1):9-13. PubMed ID: 1248188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dosage heparin in rapidly progressive glomerulonephritis.
    Fye KH; Hancock D; Moutsopoulos H; Humes HD; Arieff AI
    Arch Intern Med; 1976 Sep; 136(9):995-9. PubMed ID: 962457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotensive and diuretic effect of heparin in patients with glomerulonephritis].
    Kutyrina IM; Nikishova TA; Tareeva IE
    Ter Arkh; 1985; 57(6):78-81. PubMed ID: 4071420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
    Kutyrina IM; Nikishova TA; Tareyeva IE
    Nephrol Dial Transplant; 1987; 2(4):219-23. PubMed ID: 3118260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycans and renal function--basic and clinical aspects.
    Kovaliv YB
    Med Pregl; 2007; 60 Suppl 2():9-13. PubMed ID: 18928149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin treatment in peracute glomerulonephritis].
    Pinggera WF; Djawan S; Singer F; Stummvoll HK; Wolf A
    Wien Z Inn Med; 1973; 54(8-9):417-21. PubMed ID: 4154537
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapeutic management of consumption coagulopathy in progressive liver cirrhosis: low-dosage heparin therapy (author's transl)].
    Fischer M; Falkensammer C; Klein HJ; Irsigler K; Bruneder H; Schnack H
    Wien Klin Wochenschr; 1976 Aug; 88(15):488-94. PubMed ID: 997529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled therapeutic trial in IgA glomerulonephritis].
    Belovezhdov N; Robeva R
    Vutr Boles; 1982; 21(3):49-53. PubMed ID: 7051564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of an antiinflammatory drug (diclofenac) in primary chronic glomerulo-nephritis (author's transl)].
    Lagrue G; Hirbec G
    Sem Hop; 1979 Oct 18-25; 55(35-36):1601-5. PubMed ID: 231830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.